Four months after Theravance Biopharma shut down its R&D unit, laid off half its staff and signaled it was up for sale, the ...

Viridian Therapeutics has scored an FDA approval for Lumvoa to treat thyroid eye disease (TED), triggering competition with ...

In the past two weeks, CARsgen Therapeutics won the world's first regulatory approval for a solid tumor CAR-T Biologics' ...

The European Commission has kicked off formal proceedings in an antitrust investigation against Sanofi. The probe surrounds ...

Bayer has scored a key victory in its defense against Roundup lawsuits as the U.S. Supreme Court has tossed a $1.25 million ...

As a sweltering heat wave hit Europe, a swath of pharma companies and healthcare marketing agencies from around the world ...

Once the CHMP has delivered marketing authorization recommendations, final sign-off on the decisions must still be conferred ...

Driven by personal losses, major unmet needs and a desire to diversify from the crowded oncology market, Fosun Pharma is ...

After 35 years engaged in the research and development of pharmaceutical products, Ionis began marketing its drugs for the ...

The world’s first CAR-T therapy for solid tumors has passed muster in China, with the country's National Medical Products ...

The FDA has accused Pinnacle Biologics of creating videos that make it hard for healthcare professionals to “adequately ...

The transaction is a big splash for Merck KGaA, representing the company’s largest deal since its buyout of Sigma-Aldrich for ...